Trinity Biotech PLC
TRIB- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000888721
No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $379.5K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Trinity Biotech PLC as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −2 vs. Q3 2021
- Shares held
- 5.39M
- −126.6K (−2.3%) vs. Q3 2021
- Total value
- $7.70M
- −$4.21M (−35.3%) vs. Q3 2021
- New holders
- 4
- 5 more added
- Sold out
- 6
- 4 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRIB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $379.5K |
| Q1 2026 | 23 | $588.9K |
| Q4 2025 | 27 | $673.3K |
| Q3 2025 | 28 | $2.81M |
| Q2 2025 | 25 | $1.66M |
| Q1 2025 | 27 | $468.1K |
| Q4 2024 | 23 | $2.30M |
| Q3 2024 | 19 | $2.95M |
| Q2 2024 | 20 | $5.67M |
| Q1 2024 | 19 | $5.95M |
| Q4 2023 | 26 | $2.58M |
| Q3 2023 | 20 | $4.49M |
| Q2 2023 | 20 | $5.93M |
| Q1 2023 | 20 | $5.96M |
| Q4 2022 | 20 | $6.51M |
| Q3 2022 | 21 | $7.50M |
| Q2 2022 | 20 | $8.92M |
| Q1 2022 | 22 | $9.56M |
| Q4 2021 | 21 | $7.70M |
| Q3 2021 | 23 | $11.9M |
| Q2 2021 | 29 | $16.6M |
| Q1 2021 | 34 | $20.3M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Trinity Biotech PLC; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hunter Associates Investment Management LLC | 2,286,150 | $3.27M | 0.93% | +190,250+9.1% | Added |
| Renaissance Technologies LLC | 1,568,555 | $2.24M | 0.00% | −178,286−10.2% | Reduced |
| Acadian Asset Management LLC | 843,523 | $1.20M | 0.00% | −11,849−1.4% | Reduced |
| Stonehill Capital Management LLC | 219,946 | $315.0K | 0.07% | −268,988−55.0% | Reduced |
| Envestnet Asset Management Inc | 110,901 | $159.0K | 0.00% | +110,901 | New |
| LPL Financial LLC | 106,973 | $153.0K | 0.00% | +17,900+20.1% | Added |
| Morgan Stanley | 60,608 | $87.0K | 0.00% | +39,843+191.9% | Added |
| Millennium Management LLC | 40,756 | $58.0K | 0.00% | −23,668−36.7% | Reduced |
| Whitefort Capital Management, LP | 35,068 | $50.0K | 0.04% | +35,068 | New |
| Wealthsource Partners, LLC | 30,200 | $43.0K | 0.00% | 00.0% | Unchanged |
| State of New Jersey Common Pension Fund D | 27,062 | $39.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 22,799 | $33.0K | 0.00% | +22,799 | New |
| Citadel Advisors LLC | 18,884 | $27.0K | 0.00% | +1,240+7.0% | Added |
| Simplex Trading, LLC | 7,498 | $10.0K | 0.00% | +7,498 | New |
| UBS Group AG | 6,429 | $9.00K | 0.00% | +5,824+962.6% | Added |
| Bank of America Corp | 1,204 | $2.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 1,037 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 837 | $1.00K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 944 | $1.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Atwood & Palmer Inc | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −34,703−100.0% | Sold out |
| Navellier & Associates Inc | 0 | $0 | 0.00% | −15,485−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,427−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −10,981−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −2−100.0% | Sold out |